Medco Health Solution News

CVS CEO THOMAS RYAN RECEIVED $24.1 million in compensation in 2008, down 7.6 percent from the prior year, Drug Benefit News reported.

With our nation's capital abuzz with talk of the health-care reform that may or not come, Jim Cramer took the time to explain one corporate player that could weather the storm just fine.

Medco Health Solutions, Inc. , is the #1 pharmacy benefit manager in the country and as a corporation, ranks #45 on the Fortune 100 list.

President Barack Obama's White House health care czar earned at least $2.3 million working for health care companies in 2008 and early 2009, including several that lobby in Washington.

Medco Health Solutions, Inc. will be expanding operations in Indiana, a move that is expected to create more than 160 jobs.

President Barack Obama's White House health care czar earned at least $2.3 million working for health care companies in 2008 and early 2009, including several that lobby in Washington.

Medco Health Solutions Inc. plans to add another 160 jobs at its automated pharmacy in Whitestown, state officials announced this morning.

The State of California's efforts to move into the age of wired health care received a shot in the arm today as The California Public Employees' Retirement System joined with Anthem Blue Cross, Medco Health Solutions, Inc., and Blue Shield of California to launch the state's largest electronic prescribing initiative to date.

Spun off by Merck in August 2003, Medco Health Solutions has become the largest U.S. pharmacy benefit manager , and now it may well make a large acquisition to make sure it stays ahead of the pack in the fiercely competitive but highly profitable industry.

National pharmacy benefit management company Medco will significantly improve access to its services for limited English proficient members in 2009, the U.S. Department of Health and Human Services announced today.

Many health care stocks have performed fairly well in the last year. In spite of the down market, the health insurance and drug providers have kept their businesses robust, showing that health care has been as near to a recession-proof business as there is.

Research presented at the American Diabetes Association's 69th Scientific Sessions points to increased risk for people with diabetes associated with two widely used drug classes; while another study shed new light on a different class of drugs that faced increased scrutiny from the US Food and Drug Administration .

An independent large study conducted by MEDCO Health Solutions Inc. found that women treated with tamoxifen for breast cancer doubled the risk of the disease returning if they used antidepressants--in particular, Paxil and Prozac.

As the Obama administration readies its health policy, we already know one central feature: a proposed Institute for Comparative Effectiveness.

Breast cancer survivors risk having their disease come back if they use certain antidepressants while also taking the cancer prevention drug tamoxifen, worrisome new research shows.

Tamoxifen, a breast cancer medicine used by millions of women, doesna t work when taken with antidepressants like Eli Lilly & Co.a s Prozac, Pfizer Inc.a s Zoloft and GlaxoSmithKline Plca s Paxil, a study says.

ORLANDO, Florida - Breast cancer survivors risk having their disease come back if they use certain antidepressants while also taking the cancer prevention drug tamoxifen, worrisome new research shows.

Companies mentioned in this article: Medco Health Solutions, Inc. - Several SSRIs more than double risk of cancer recurrence in tamoxifen treated patients - Nearly 30 percent of tamoxifen users take drugs that reduce its effectiveness against breast cancer ORLANDO, Fla.

The Bureau County Health and Wellness Clinic will receive $125,000 as the result of $2.7 million in pharmaceutical lawsuit settlements announced Tuesday by Illinois Attorney General Lisa Madigan.

Illinois Attorney General Lisa Madigan says two dozen nonprofit health clinics will split $2.7 million in settlement funds to help buy prescription drugs for low-income patients.